131 related articles for article (PubMed ID: 35184602)
1. Retrospective Evaluation of Intrapleural Tissue Plasminogen Activator With or Without Dornase Alfa for the Treatment of Traumatic Retained Hemothorax: A 6-Year Experience.
Janowak CF; Becker BR; Philpott CD; Makley AT; Mueller EW; Droege CA; Droege ME
Ann Pharmacother; 2022 Feb; ():10600280221077383. PubMed ID: 35184602
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of Intrapleural Tissue Plasminogen Activator and Dornase Alfa vs Tissue Plasminogen Activator Alone in Children with Pleural Empyema: A Randomized Clinical Trial.
Livingston MH; Mahant S; Connolly B; MacLusky I; Laberge S; Giglia L; Yang C; Roberts A; Shawyer A; Brindle M; Parsons S; Stoian C; Walton JM; Thorpe KE; Chen Y; Zuo F; Mamdani M; Chan C; Loong D; Isaranuwatchai W; Ratjen F; Cohen E
JAMA Pediatr; 2020 Apr; 174(4):332-340. PubMed ID: 32011642
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of chest tube administration of tissue plasminogen activator to treat retained hemothorax.
Stiles PJ; Drake RM; Helmer SD; Bjordahl PM; Haan JM
Am J Surg; 2014 Jun; 207(6):960-3. PubMed ID: 24495319
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy and bleeding outcomes of tissue plasminogen activator and dornase alfa in pleural space infection with once daily concurrent administration: a retrospective cohort study.
Jiang C; Xie M; Cervellione K; Thurm C
BMC Res Notes; 2020 Aug; 13(1):368. PubMed ID: 32746902
[TBL] [Abstract][Full Text] [Related]
5. Rethinking the Doses of Tissue Plasminogen Activator and Deoxyribonuclease Administrated Concurrently for Intrapleural Therapy for Complicated Pleural Effusion and Empyema.
Innabi A; Surana A; Alzghoul B; Meena N
Cureus; 2018 Feb; 10(2):e2214. PubMed ID: 30755840
[TBL] [Abstract][Full Text] [Related]
6. Intrapleural tissue plasminogen activator and deoxyribonuclease administered concurrently and once daily for complex parapneumonic pleural effusion and empyema.
Smith D; Shaw H; Ryder T
Intern Med J; 2023 Dec; 53(12):2313-2318. PubMed ID: 37029951
[TBL] [Abstract][Full Text] [Related]
7. Concurrent Intrapleural Instillation of Tissue Plasminogen Activator and DNase for Pleural Infection. A Single-Center Experience.
Majid A; Kheir F; Folch A; Fernandez-Bussy S; Chatterji S; Maskey A; Fashjian M; Cheng G; Ochoa S; Alape D; Folch E
Ann Am Thorac Soc; 2016 Sep; 13(9):1512-8. PubMed ID: 27333122
[TBL] [Abstract][Full Text] [Related]
8. Choice of intrapleural fibrinolytic agents in the treatment of adult complicated parapneumonic effusion and empyema: Network meta-analysis.
Yokoyama Y; Kuno T; Takagi H; Burfeind W
Asian Cardiovasc Thorac Ann; 2023 Jun; 31(5):451-458. PubMed ID: 37287257
[TBL] [Abstract][Full Text] [Related]
9. Alteplase Dose Assessment for Pleural infection Therapy (ADAPT) Study-2: Use of 2.5 mg alteplase as a starting intrapleural dose.
Popowicz N; Ip H; Lau EPM; Piccolo F; Dootson K; Yeoh C; Phu WY; Brown R; West A; Ahmed L; Lee YCG
Respirology; 2022 Jul; 27(7):510-516. PubMed ID: 35441458
[TBL] [Abstract][Full Text] [Related]
10. Intrapleural Tissue Plasminogen Activator for Traumatic Retained Hemothorax.
Holsen MR; Tameron AM; Evans DC; Thompson M
Ann Pharmacother; 2019 Oct; 53(10):1060-1066. PubMed ID: 31007039
[No Abstract] [Full Text] [Related]
11. Predictive Variables for Failure in Administration of Intrapleural Tissue Plasminogen Activator/Deoxyribonuclease in Patients With Complicated Parapneumonic Effusions/Empyema.
Khemasuwan D; Sorensen J; Griffin DC
Chest; 2018 Sep; 154(3):550-556. PubMed ID: 29425674
[TBL] [Abstract][Full Text] [Related]
12. Safety and Efficacy of Tissue Plasminogen Activator and DNase for Complicated Pleural Effusions Secondary to Abdominal Pathology.
Majid A; Ochoa S; Chatterji S; Fernandez-Bussy S; Kheir F; Rivera E; Cheng G; Folch E
Ann Am Thorac Soc; 2017 Mar; 14(3):342-346. PubMed ID: 28079399
[TBL] [Abstract][Full Text] [Related]
13. Hemothorax With White-Out Lung After Intrapleural Tissue Plasminogen Activator and Deoxyribonuclease Therapy in a Patient With Complicated Parapneumonic Effusion.
Mainali A; Adhikari S; Chowdhury T; Gousy N; Bisural R; Devkota S; Kaphle Bastola AD
Cureus; 2022 Jun; 14(6):e26208. PubMed ID: 35891847
[TBL] [Abstract][Full Text] [Related]
14. Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery.
Piccolo F; Pitman N; Bhatnagar R; Popowicz N; Smith NA; Brockway B; Nickels R; Burke AJ; Wong CA; McCartney R; Choo-Kang B; Blyth KG; Maskell NA; Lee YC
Ann Am Thorac Soc; 2014 Nov; 11(9):1419-25. PubMed ID: 25296241
[TBL] [Abstract][Full Text] [Related]
15. Understanding the systemic effects of intrapleural tPA and DNase by evaluating effects on coagulation.
Marston TW; Rajdev K; Samson KK; Hershberger DM
J Thorac Dis; 2024 Jan; 16(1):91-98. PubMed ID: 38410602
[TBL] [Abstract][Full Text] [Related]
16. A combined intrapleural administration of dornase alfa and tissue plasminogen activator is safe in children with empyema - A pilot study.
Slaats MA; De Dooy J; Van Hoorenbeeck K; Van Schil PEY; Verhulst SL; Hendriks JMH
Acta Chir Belg; 2021 Jun; 121(3):184-188. PubMed ID: 31750793
[TBL] [Abstract][Full Text] [Related]
17. Lytic Therapy for Retained Traumatic Hemothorax: A Systematic Review and Meta-analysis.
Hendriksen BS; Kuroki MT; Armen SB; Reed MF; Taylor MD; Hollenbeak CS
Chest; 2019 Apr; 155(4):805-815. PubMed ID: 30664856
[TBL] [Abstract][Full Text] [Related]
18. Intrapleural Dornase and Tissue Plasminogen Activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial.
Livingston MH; Mahant S; Ratjen F; Connolly BL; Thorpe K; Mamdani M; Maclusky I; Laberge S; Giglia L; Walton JM; Yang CL; Roberts A; Shawyer AC; Brindle M; Parsons SJ; Stoian CA; Cohen E
Trials; 2017 Jun; 18(1):293. PubMed ID: 28646887
[TBL] [Abstract][Full Text] [Related]
19. The cost of treatments for retained traumatic hemothorax: A decision analysis.
Wong WG; Perez Holguin RA; Oh JS; Armen SB; Taylor MD; Reed MF; Hollenbeak CS
Injury; 2022 Sep; 53(9):2930-2938. PubMed ID: 35871855
[TBL] [Abstract][Full Text] [Related]
20. Intrapleural Fibrinolytics and Deoxyribonuclease for Treatment of Indwelling Pleural Catheter-Related Pleural Infection: A Multi-Center Observational Study.
Fitzgerald DB; Muruganandan S; Tsim S; Ip H; Asciak R; Walker S; Uribe Becerra JP; Majid A; Ahmed L; Rahman NM; Maskell NA; Blyth KG; Lee YCG
Respiration; 2021; 100(5):452-460. PubMed ID: 33784710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
